Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Löwenberg

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|May 3, 2008
Diagnosis and prognosis in acute myeloid leukemia--the art of distinctionBob Löwenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
On the road to new drugs in acute myeloid leukemiaBob Löwenberg
The New England Journal of Medicine|October 10, 2003
Minimal residual disease in chronic myeloid leukemiaBob Löwenberg
Blood|December 5, 2015
Blood's 70th anniversary: a rich historyBob Löwenberg
Blood|February 5, 2017
Introduction to the review series on leukemic stem cellsBob Löwenberg
Blood|January 5, 2013
Sense and nonsense of high-dose cytarabine for acute myeloid leukemiaBob Löwenberg
Blood|November 17, 2017
Introduction to a review series on hematologic disease at older ageBob Löwenberg
Hematology. American Society of Hematology. Education Program|December 17, 2008
Acute myeloid leukemia: the challenge of capturing disease varietyBob Löwenberg
Blood|January 24, 2019
Introduction to a review series on myelodysplastic syndromesBob Löwenberg
Blood|June 12, 2020
The long road: improving outcome in elderly "unfit" AML?Bob Löwenberg, Gerwin Huls
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|May 3, 2008
Diagnosis and prognosis in acute myeloid leukemia--the art of distinctionBob Löwenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
On the road to new drugs in acute myeloid leukemiaBob Löwenberg
The New England Journal of Medicine|October 10, 2003
Minimal residual disease in chronic myeloid leukemiaBob Löwenberg
Blood|December 5, 2015
Blood's 70th anniversary: a rich historyBob Löwenberg
Blood|February 5, 2017
Introduction to the review series on leukemic stem cellsBob Löwenberg
Blood|January 5, 2013
Sense and nonsense of high-dose cytarabine for acute myeloid leukemiaBob Löwenberg
Blood|November 17, 2017
Introduction to a review series on hematologic disease at older ageBob Löwenberg
Hematology. American Society of Hematology. Education Program|December 17, 2008
Acute myeloid leukemia: the challenge of capturing disease varietyBob Löwenberg
Blood|January 24, 2019
Introduction to a review series on myelodysplastic syndromesBob Löwenberg
Blood|June 12, 2020
The long road: improving outcome in elderly "unfit" AML?Bob Löwenberg, Gerwin Huls
Pageof 25